Results 201 to 210 of about 213,682 (259)

Semi-annual and annual mass drug administration of diethylcarbamazine and albendazole are equally effective regimens for eliminating lymphatic filariasis in Papua New Guinea. [PDF]

open access: yesPLoS Negl Trop Dis
Payne MC   +9 more
europepmc   +1 more source

Building capacity to treat childhood cancer in Papua New Guinea: 'It's a multidisciplinary village'. [PDF]

open access: yesJ Glob Health
Raj TAS   +9 more
europepmc   +1 more source

High rates of suppurative otitis media among children attending urban clinics in Goroka, Eastern Highlands Province, Papua New Guinea: a cross-sectional study. [PDF]

open access: yesLancet Reg Health West Pac
Aho C   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Nutrition Studies in New Guinea

The American Journal of Clinical Nutrition, 1964
The results of nutritional studies are reported which were carried out in Papuan subjects living in the Central Highlands of New Guinea where 90 to 95 per cent of the staple food consists of sweet potatoes. The daily protein intake is 15 to 35 gm. The protein is poor in the amino acids methionine, cystine and to a lesser degree in lysine.Nitrogen ...
R. LUYKEN   +3 more
openaire   +3 more sources

New Guinea

2003
New Guinea, the world's largest tropical island, is a land of great contrasts, ranging from small glaciers on its highest peaks to broad mangrove swamps in its lowlands and hundreds of smaller islands and coral atolls along its coasts. Divided between two nations, the island and its neighboring archipelagos form Indonesia's Papua Province (or Irian ...
  +6 more sources

A New Transferrin in New Guinea

Nature, 1963
IN 1957 Smithies1, using the technique of starch-gel electrophoresis, described inherited variants of human β-globulins. Smithies and Hiller2 established the identity of these β-globulins with the iron-binding protein, trans-ferrin, and this was afterwards confirmed with iron-59 and autoradiography3.
openaire   +2 more sources

Home - About - Disclaimer - Privacy